Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 November 2022 | Story Edzani Nephalela and Dr Nomalungelo Ngubane | Photo iStock
Language
The UFS and UKZN have formalised an agreement on a Language Collaboration Memorandum of Understanding (MOU) to advance the development of the Sesotho and IsiZulu as academic languages.

The University of the Free State (UFS) has forged an exciting new partnership with the University of KwaZulu-Natal (UKZN) to promote the two provinces’ most widely spoken languages, Sesotho and IsiZulu.  

This historic collaboration will see these institutions employing their skills, expertise, and resources to advance the development of the Sesotho and IsiZulu as academic languages through the development of terminology for various disciplines and research collaborations among other activities. 

The UFS formalised the agreement by signing a Language Collaboration Memorandum of Understanding (MOU) with UKZN. The MOU process, facilitated by Dr Nomalungelo Ngubane, Director of the UFS Academy for Multilingualism, and Nikile Ntsababa, UFS Registrar, was sealed by Dr Engela Van Staden, UFS Vice-Rector: Academic. 

The objectives of the collaboration are to: 

• allow the UFS open access to all the UKZN isiZulu materials and UKZN open access to all UFS Sesotho language terminology, corpus materials, terminology banks, and applications for various disciplines; 
• develop the Sesotho terminology for various disciplines;
• assist in identifying and closing any gaps in the UFS’s development of isiZulu terminology and in the UKZN’s development of isiZulu, and further develop the relevant language terminology of various disciplines in order to fill any existing gaps;
• share expertise through hosting webinars, seminars, colloquia, and workshops on Sesotho and isiZulu terminology development;
• explore research opportunities regarding the development of Sesotho and isiZulu terminology for various disciplines; and 
• share expertise and resources in all human language technology development initiatives.

“The UKZN has championed the intellectualisation of IsiZulu over the years. We do not want to reinvent the wheel,” Dr Ngubane said. “Our focus now is on the acceleration of the development of Sesotho. Our vision and mission is to be the hub for the advancement of Sesotho at regional, national, and international levels. Collaboration with UKZN is instrumental in achieving this mandate.”

The Academy for Multilingualism said it considers this collaboration historic and groundbreaking because resources will now be invested in the development of Sesotho.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept